GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | 8/15/2026 4:03:58 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $2,069,562 | EPS -$1.19 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 6/18/2026 4:06:20 PM | View | Proxy | SEC | Y 2025 | ||||||
| Processa Pharmaceuticals, Inc. (PCSA) | 5/7/2026 4:39:38 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $4,520,974 | EPS -$1.29 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 4/30/2026 5:24:16 PM | Micro | View | Financials | 10-K/A | SEC | Y 2025 ending: 12/31/2025 | Assets $7,813,567 | EPS -$10.36 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 3/18/2026 4:14:54 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $7,813,567 | EPS -$10.36 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 11/6/2025 4:24:26 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $7,584,576 | EPS -$0.07 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 8/13/2025 8:31:12 AM | View | Proxy | SEC | Y 2024 | ||||||
| Processa Pharmaceuticals, Inc. (PCSA) | 8/7/2025 9:02:33 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $8,181,789 | EPS -$0.25 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 5/12/2025 4:07:47 PM | View | Proxy | SEC | Y 2024 | ||||||
| Processa Pharmaceuticals, Inc. (PCSA) | 5/8/2025 4:13:14 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $4,809,574 | EPS -$0.30 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 3/20/2025 4:44:24 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $3,229,289 | EPS -$3.87 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 10/30/2024 4:24:55 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $4,942,152 | EPS -$1.03 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 8/13/2024 4:29:40 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $7,600,976 | EPS -$1.01 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 6/11/2024 2:20:51 PM | View | Proxy | SEC | Y 2023 | ||||||
| Processa Pharmaceuticals, Inc. (PCSA) | 5/10/2024 4:26:52 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $9,944,732 | EPS -$1.11 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 4/29/2024 4:59:33 PM | View | Proxy | SEC | Y 2023 | ||||||
| Processa Pharmaceuticals, Inc. (PCSA) | 3/29/2024 4:17:09 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $5,786,643 | EPS -$8.48 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 11/13/2023 4:16:56 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $8,082,726 | EPS -$0.08 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 10/5/2023 10:01:42 AM | View | Proxy | SEC | Y 2022 | ||||||
| Processa Pharmaceuticals, Inc. (PCSA) | 8/10/2023 4:27:46 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $10,090,423 | EPS -$0.10 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 5/15/2023 10:11:51 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $12,432,443 | |||
| Processa Pharmaceuticals, Inc. (PCSA) | 5/1/2023 10:01:37 AM | View | Proxy | SEC | Y 2022 | ||||||
| Processa Pharmaceuticals, Inc. (PCSA) | 3/31/2023 8:33:10 AM | View | Financials | Earnings | SEC | Y 2022 | Assets $8,619,851 | Export Earnings Model | |||
| Processa Pharmaceuticals, Inc. (PCSA) | 3/30/2023 4:21:12 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $8,619,851 | |||
| Processa Pharmaceuticals, Inc. (PCSA) | 11/8/2022 4:15:55 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $18,604,465 | |||
| Processa Pharmaceuticals, Inc. (PCSA) | 11/8/2022 4:10:28 PM | View | Financials | Earnings | SEC | 3Q 2022 | Assets $18,604,465 | Export Earnings Model | |||
| Processa Pharmaceuticals, Inc. (PCSA) | 8/12/2022 10:37:27 AM | View | Financials | Earnings | SEC | 2Q 2022 | Assets $21,657,590 | Export Earnings Model | |||
| Processa Pharmaceuticals, Inc. (PCSA) | 8/11/2022 4:19:26 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $21,657,590 | |||
| Processa Pharmaceuticals, Inc. (PCSA) | 5/31/2022 8:01:55 AM | View | Proxy | SEC | Y 2021 | ||||||
| Processa Pharmaceuticals, Inc. (PCSA) | 5/12/2022 4:28:31 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $24,300,792 | |||
| Processa Pharmaceuticals, Inc. (PCSA) | 5/12/2022 4:27:05 PM | View | Financials | Earnings | SEC | 1Q 2022 | Assets $24,300,792 | Export Earnings Model | |||
| Processa Pharmaceuticals, Inc. (PCSA) | 5/2/2022 4:09:29 PM | Micro | View | Financials | 10-K/A | SEC | Y 2021 ending: 12/31/2021 | Assets $26,463,505 | |||
| Processa Pharmaceuticals, Inc. (PCSA) | 3/30/2022 4:16:24 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $26,463,505 | |||
| Processa Pharmaceuticals, Inc. (PCSA) | 3/30/2022 4:01:35 PM | View | Financials | Earnings | WIRE | Y 2021 | Assets $26,463,505 | Export Earnings Model | |||
| Processa Pharmaceuticals, Inc. (PCSA) | 11/12/2021 6:24:34 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $29,025,295 | |||
| Processa Pharmaceuticals, Inc. (PCSA) | 11/11/2021 4:06:50 PM | View | Financials | Earnings | WIRE | 3Q 2021 | Assets $29,025,295 | Export Earnings Model | |||
| Processa Pharmaceuticals, Inc. (PCSA) | 9/20/2021 2:56:36 PM | View | Proxy | SEC | Y 2020 | ||||||
| Processa Pharmaceuticals, Inc. (PCSA) | 8/13/2021 6:17:45 AM | View | Financials | Earnings | SEC | 2Q 2021 | Assets $31,137,959 | Export Earnings Model | |||
| Processa Pharmaceuticals, Inc. (PCSA) | 8/12/2021 4:12:23 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $31,137,959 | |||
| Processa Pharmaceuticals, Inc. (PCSA) | 8/12/2021 7:07:00 AM | View | Financials | Earnings | WIRE | 2Q 2021 | Assets $31,137,959 | Export Earnings Model | |||
| Processa Pharmaceuticals, Inc. (PCSA) | 5/13/2021 5:29:18 PM | View | Financials | Earnings | SEC | 1Q 2021 | Assets $33,338,160 | Export Earnings Model | |||
| Processa Pharmaceuticals, Inc. (PCSA) | 5/13/2021 4:46:04 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $33,338,160 | |||
| Processa Pharmaceuticals, Inc. (PCSA) | 4/22/2021 2:00:58 PM | View | Proxy | SEC | Y 2020 | ||||||
| Processa Pharmaceuticals, Inc. (PCSA) | 3/25/2021 7:42:08 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Assets $25,214,389 | EPS -$2.54 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 11/12/2020 5:03:35 PM | View | Financials | Earnings | WIRE | 3Q 2020 | Assets $9,589,176 | EPS -$0.55 | Export Earnings Model | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 11/12/2020 4:15:59 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $9,589,176 | EPS -$0.55 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 8/5/2020 3:48:47 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Assets $10,011,456 | EPS -$0.13 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 5/27/2020 5:16:16 PM | View | Proxy | SEC | Y 2019 | ||||||
| Processa Pharmaceuticals, Inc. (PCSA) | 5/15/2020 1:38:50 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Assets $10,012,026 | EPS -$0.16 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 3/6/2020 5:23:35 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Assets $10,883,134 | EPS -$0.70 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 11/25/2019 2:31:48 PM | View | Proxy | SEC | Y 2018 | ||||||
| Processa Pharmaceuticals, Inc. (PCSA) | 11/14/2019 12:08:21 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Assets $10,821,293 | EPS -$0.16 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 8/14/2019 12:44:24 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Assets $11,305,628 | EPS -$0.18 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 7/18/2019 2:34:57 PM | View | Proxy | SEC | Y 2018 | ||||||
| Processa Pharmaceuticals, Inc. (PCSA) | 5/14/2019 1:24:50 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Assets $12,077,897 | EPS -$0.14 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 4/26/2019 5:04:01 PM | View | Proxy | SEC | Y 2018 | ||||||
| Processa Pharmaceuticals, Inc. (PCSA) | 4/8/2019 6:13:57 AM | Micro | View | Financials | 10-K/A | SEC | Y 2018 ending: 12/31/2018 | Assets $12,481,068 | EPS -$0.71 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 3/28/2019 5:36:06 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Assets $12,481,068 | EPS -$0.71 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 11/14/2018 6:25:36 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Assets $13,462,943 | EPS -$0.02 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 8/14/2018 5:36:21 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Assets $14,437,672 | EPS -$0.03 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 5/21/2018 12:58:31 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Assets $12,886,250 | EPS -$0.03 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 4/16/2018 6:13:54 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Assets $2,982,940 | EPS -$0.06 | ||
| Processa Pharmaceuticals, Inc. (PCSA) | 11/20/2017 3:45:49 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Assets $80,262 | EPS -$0.02 | ||
| Heatwurx, Inc. (PCSA) | 10/4/2017 4:35:45 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Assets $1,949 | EPS -$0.01 | ||
| Heatwurx, Inc. (PCSA) | 10/4/2017 10:24:11 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Assets $1,639 | EPS -$0.01 | ||
| Heatwurx, Inc. (PCSA) | 9/25/2017 12:34:24 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $5,000 -95.6% | Assets $2,364,921 | EPS -$0.07 | |
| Heatwurx, Inc. (PCSA) | 9/8/2017 3:45:59 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Assets $35,234 | EPS -$0.03 | ||
| Heatwurx, Inc. (PCSA) | 8/30/2017 4:53:29 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Assets $43,498 | EPS -$0.02 | ||
| Heatwurx, Inc. (PCSA) | 8/7/2017 5:04:00 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $5,000 -86.8% | Assets $47,340 | EPS -$0.01 | |
| Heatwurx, Inc. (PCSA) | 6/19/2017 2:53:32 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $113,425 +5.8% | Assets $104,321 | EPS -$0.31 | |
| Heatwurx, Inc. (PCSA) | 12/1/2015 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Rev: $58,165 +10.5% | Assets $498,144 | EPS -$0.03 | |
| Heatwurx, Inc. (PCSA) | 8/19/2015 3:59:57 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Rev: $20,040 -91.1% | Assets $877,714 | EPS -$0.19 | |
| Heatwurx, Inc. (PCSA) | 5/15/2015 2:20:53 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Rev: $37,760 -7.4% | Assets $2,543,020 | EPS -$0.06 | |
| Heatwurx, Inc. (PCSA) | 4/14/2015 5:00:08 PM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Rev: $107,239 -82.8% | Assets $2,545,862 | EPS -$0.68 | |
| Heatwurx, Inc. (PCSA) | 11/13/2014 4:56:21 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Rev: $52,621 -79.1% | Assets $2,666,677 | EPS -$0.10 | |
| Heatwurx, Inc. (PCSA) | 8/19/2014 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Rev: $225,670 +16.0% | Assets $2,784,698 | EPS -$0.11 | |
| Heatwurx, Inc. (PCSA) | 5/14/2014 3:44:39 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Rev: $40,780 +6.2% | Assets $2,907,620 | EPS -$0.17 | |
| Heatwurx, Inc. (PCSA) | 3/27/2014 3:39:38 PM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Rev: $624,960 +62.6% | Assets $2,938,053 | EPS -$0.61 | |
| Heatwurx, Inc. (PCSA) | 11/8/2013 4:42:12 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Rev: $251,820 +156.7% | Assets $3,843,050 | EPS -$0.12 | |
| Heatwurx, Inc. (PCSA) | 9/6/2013 4:14:10 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2013 ending: 6/30/2013 | Rev: $194,560 +0.3% | Assets $3,467,367 | EPS -$0.34 |